Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies

Giovanni Triolo, Francesco Ciccia, Vasiliki Liakouli, Francesco Carubbi, Paola Di Benedetto, Piero Ruscitti, Onorina Berardicurti, Roberto Giacomelli, Paola Cipriani

    Risultato della ricerca: Articlepeer review

    13 Citazioni (Scopus)

    Abstract

    In recent years, mesenchymal stromal cells (MSCs) have been largely investigated and tested as a new therapeutic tool for several clinical applications, including the treatment of different rheumatic diseases. MSCs are responsible for the normal turnover and maintenance of adult mesenchymal tissues as the result of their multipotent differentiation abilities and their secretion of a variety of cytokines and growth factors. Although initially derived from bone marrow, MSCs are present in many different tissues such as many peri-articular tissues. MSCs may exert immune-modulatory properties, modulating different immune cells in both in vitro and in vivo models, and they are considered immune-privileged cells. At present, these capacities are considered the most intriguing aspect of their biology, introducing the possibility that these cells may be used as effective therapy in autoimmune diseases. Therefore, stem cell therapies may represent an innovative approach for the treatment of rheumatic diseases, especially for the forms that are not responsive to standard treatments or alternatively still lacking a definite therapy. At present, although the data from scientific literature appear to suggest that such treatments might be more effective whether administered as soon as possible, the use of MSCs in clinical practice is likely to be restricted to patients with a long history of a severe refractory disease. Further results from larger clinical trials are needed to corroborate preclinical findings and human non-controlled studies, and advancement in the knowledge of MSCs might provide information about the therapeutic role of these cells in the treatment of many rheumatic diseases.
    Lingua originaleEnglish
    pagine (da-a)832-49-
    Numero di pagine8
    RivistaCytotherapy
    Volume17
    Stato di pubblicazionePublished - 2015

    All Science Journal Classification (ASJC) codes

    • Immunology and Allergy
    • Immunology
    • Oncology
    • Genetics(clinical)
    • Cell Biology
    • Transplantation
    • Cancer Research

    Fingerprint Entra nei temi di ricerca di 'Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies'. Insieme formano una fingerprint unica.

    Cita questo